Cargando…

Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer

Discoidin domain receptor 1 (DDR1) has been demonstrated to be able to promote tumor invasion and metastasis and being closely related to tumor immune infiltration. However, DDR1 has rarely been studied in gastric cancer. Here, we primarily evaluated DDR1 expression in gastric cancer and its cell li...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Songna, Fu, Yuan, Kuerban, Kudelaidi, Liu, Jiayang, Huang, Xuan, Pan, Danjie, Chen, Huaning, Zhu, Yizhun, Ye, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353406/
https://www.ncbi.nlm.nih.gov/pubmed/35935941
http://dx.doi.org/10.3389/fimmu.2022.933165
_version_ 1784762860153339904
author Wang, Songna
Fu, Yuan
Kuerban, Kudelaidi
Liu, Jiayang
Huang, Xuan
Pan, Danjie
Chen, Huaning
Zhu, Yizhun
Ye, Li
author_facet Wang, Songna
Fu, Yuan
Kuerban, Kudelaidi
Liu, Jiayang
Huang, Xuan
Pan, Danjie
Chen, Huaning
Zhu, Yizhun
Ye, Li
author_sort Wang, Songna
collection PubMed
description Discoidin domain receptor 1 (DDR1) has been demonstrated to be able to promote tumor invasion and metastasis and being closely related to tumor immune infiltration. However, DDR1 has rarely been studied in gastric cancer. Here, we primarily evaluated DDR1 expression in gastric cancer and its cell lines using multiple databases. Subsequently, the cancer prognosis was investigated in relation to DDR1 expression. After analysis, we discovered that DDR1 was highly expressed and significantly connected with poor prognosis in gastric cancer. To comprehensively understand the molecular mechanism of DDR1, we explored genes and proteins interacting with DDR1 in gastric cancer using databases. Additionally, we found that the expression level of DDR1 was inversely correlated with immune infiltration and significantly relative to various immune cell markers. Overall, DDR1 was implicated in invasion, metastasis, and immune infiltration of gastric cancer. Inhibition of DDR1 may have the potential to alleviate the strong invasiveness and metastasis of advanced gastric cancer. Meanwhile, immune exclusion by DDR1 may also provide a new strategy for improving the efficacy of immune checkpoints inhibitors (ICIs), such as programmed cell death protein 1 (PD-1) antibody.
format Online
Article
Text
id pubmed-9353406
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93534062022-08-06 Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer Wang, Songna Fu, Yuan Kuerban, Kudelaidi Liu, Jiayang Huang, Xuan Pan, Danjie Chen, Huaning Zhu, Yizhun Ye, Li Front Immunol Immunology Discoidin domain receptor 1 (DDR1) has been demonstrated to be able to promote tumor invasion and metastasis and being closely related to tumor immune infiltration. However, DDR1 has rarely been studied in gastric cancer. Here, we primarily evaluated DDR1 expression in gastric cancer and its cell lines using multiple databases. Subsequently, the cancer prognosis was investigated in relation to DDR1 expression. After analysis, we discovered that DDR1 was highly expressed and significantly connected with poor prognosis in gastric cancer. To comprehensively understand the molecular mechanism of DDR1, we explored genes and proteins interacting with DDR1 in gastric cancer using databases. Additionally, we found that the expression level of DDR1 was inversely correlated with immune infiltration and significantly relative to various immune cell markers. Overall, DDR1 was implicated in invasion, metastasis, and immune infiltration of gastric cancer. Inhibition of DDR1 may have the potential to alleviate the strong invasiveness and metastasis of advanced gastric cancer. Meanwhile, immune exclusion by DDR1 may also provide a new strategy for improving the efficacy of immune checkpoints inhibitors (ICIs), such as programmed cell death protein 1 (PD-1) antibody. Frontiers Media S.A. 2022-07-22 /pmc/articles/PMC9353406/ /pubmed/35935941 http://dx.doi.org/10.3389/fimmu.2022.933165 Text en Copyright © 2022 Wang, Fu, Kuerban, Liu, Huang, Pan, Chen, Zhu and Ye https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wang, Songna
Fu, Yuan
Kuerban, Kudelaidi
Liu, Jiayang
Huang, Xuan
Pan, Danjie
Chen, Huaning
Zhu, Yizhun
Ye, Li
Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer
title Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer
title_full Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer
title_fullStr Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer
title_full_unstemmed Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer
title_short Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer
title_sort discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353406/
https://www.ncbi.nlm.nih.gov/pubmed/35935941
http://dx.doi.org/10.3389/fimmu.2022.933165
work_keys_str_mv AT wangsongna discoidindomainreceptor1isapotentialtargetcorrelatedwithtumorinvasionandimmuneinfiltrationingastriccancer
AT fuyuan discoidindomainreceptor1isapotentialtargetcorrelatedwithtumorinvasionandimmuneinfiltrationingastriccancer
AT kuerbankudelaidi discoidindomainreceptor1isapotentialtargetcorrelatedwithtumorinvasionandimmuneinfiltrationingastriccancer
AT liujiayang discoidindomainreceptor1isapotentialtargetcorrelatedwithtumorinvasionandimmuneinfiltrationingastriccancer
AT huangxuan discoidindomainreceptor1isapotentialtargetcorrelatedwithtumorinvasionandimmuneinfiltrationingastriccancer
AT pandanjie discoidindomainreceptor1isapotentialtargetcorrelatedwithtumorinvasionandimmuneinfiltrationingastriccancer
AT chenhuaning discoidindomainreceptor1isapotentialtargetcorrelatedwithtumorinvasionandimmuneinfiltrationingastriccancer
AT zhuyizhun discoidindomainreceptor1isapotentialtargetcorrelatedwithtumorinvasionandimmuneinfiltrationingastriccancer
AT yeli discoidindomainreceptor1isapotentialtargetcorrelatedwithtumorinvasionandimmuneinfiltrationingastriccancer